Home Pharmaceutics NLS Pharmaceuticals AG (NASDAQ:NLSP) Sees Significant Drop in Short-Term Interest

NLS Pharmaceuticals AG (NASDAQ:NLSP) Sees Significant Drop in Short-Term Interest


NLS Pharmaceuticals SA (NASDAQ: NLSPGet a rating) was the target of a significant drop in short-term rates during the month of July. As of July 15, there was short interest totaling 102,400 shares, down 28.3% from the June 30 total of 142,800 shares. Based on an average daily volume of 227,300 shares, the short interest ratio is currently 0.5 days. Currently, 0.8% of the company’s shares are sold short.

Changes to analyst ratings

Separately, Alliance Global Partners began covering NLS Pharmaceuticals shares in a research report on Tuesday, July 5. They issued a “buy” rating on the stock.

NLS Pharmaceuticals stock down 4.5%

Shares of NLS Pharmaceuticals Stock opened at $0.37 on Friday. The company’s fifty-day moving average price is $0.58 and its two-hundred-day moving average price is $0.90. NLS Pharmaceuticals has a 1 year minimum of $0.33 and a 1 year maximum of $3.10.

NLS Pharmaceutical Company Profile

(Get a rating)

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focused on developing treatments for narcolepsy, idiopathic hypersomnia and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).

Recommended Stories

Get news and reviews for NLS Pharmaceuticals Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for NLS Pharmaceutics and related companies with MarketBeat.com’s FREE daily newsletter.